Fresenius Kabi, a part of Fresenius, and a leading provider of essential medicines and medical technologies, announced today that the Centers for Medicare & Medicaid Services has issued ...
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced new in vitro findings demonstrating that izicopan ...
Researchers are advancing CAR T-cell therapy for solid tumors using armored cells that deliver IL-36γ. Expanded manufacturing ...
The wheal size on a skin prick test and interleukin-10 T-cell responses may predict which sensitized children with asthma will have a response to cockroach nasal challenge.
The Food and Drug Administration said in its safety alert that a review of studies, documents from avacopan manufacturer ...
Liver disease is rapidly emerging as a major global health burden, with cirrhosis contributing significantly to mortality ...
The American Society of Hematology (ASH) released guidelines on the diagnosis and management of severe acquired aplastic ...
Funding received in the initial years after an investigator first establishes their research lab can be pivotal in helping to ...
When someone gets a bad infection, the body's immune system rushes in to fight the germs. But sometimes this defense system becomes too strong and starts hurting the person's own tissues and organs.
VolitionRx Limited (AMEX:VNRX) Q4 2025 Earnings Call Transcript April 1, 2026 Operator: Good morning, ladies and gentlemen, ...
First FDA-approved gene therapy for children with severe LAD-I due to biallelic variants in ITGB2Severe LAD-I is an ...
MedPage Today on MSN
FDA Warns of Fatal Liver Injuries Tied to Drug It Wants Pulled From Market
Eight deaths and dozens of DILI cases linked to avacopan for ANCA-associated vasculitis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results